Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study-Reference-Cited by-同舟云学术

Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study

Published:2016-04 Issue:4 Volume:3 Page:358-366
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Wimberley Theresa,Støvring Henrik,Sørensen Holger J,Horsdal Henriette T,MacCabe James H,Gasse Christiane

Funder

European Community's Seventh Framework Programme

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference38 articles.

1. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology;Barnes;J Psychopharmacol,2011

2. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. Updated edition. National clinical guideline number 82,2009

3. Geographic and clinical variation in clozapine use in the United States;Stroup;Psychiatr Serv,2014

4. Psychotropic prescription practices in east Asia: looking back and peering ahead;Tan;Curr Opin Psychiatry,2008

5. Geographical and temporal variations in clozapine prescription for schizophrenia;Nielsen;Eur Neuropsychopharmacol,2012

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia;Biomolecules;2024-09-06

2. Prevalence of treatment-resistant schizophrenia among people with early psychosis and its clinical and demographic correlates;Australian & New Zealand Journal of Psychiatry;2024-08-28

3. Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patients;European Archives of Psychiatry and Clinical Neuroscience;2024-08-28

4. Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice;European Neuropsychopharmacology;2024-07

5. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis;CNS Drugs;2024-07-01